Request Demo
Last update 14 Apr 2025
Docetaxel albumin bound
Last update 14 Apr 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Albumin-bound docetaxel, Nab-docetaxel, ABI-008 + [4] |
Target |
Action inhibitors |
Mechanism Tubulin inhibitors |
Therapeutic Areas |
Active Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
RegulationOrphan Drug (United States) |
Login to view timeline
Related
32
Clinical Trials associated with Docetaxel albumin boundNCT06747338
A Randomized, Controlled, Open-label, Multicenter, Phase III Clinical Trial to Compare the Efficacy and Safety of KN026 Combined With HB1801 Versus Trastuzumab Combined With Pertuzumab and Docetaxel in Neoadjuvant Treatment of Early or Locally Advanced HER2-positive Breast Cancer.
CTR20242289
一项评估谷美替尼联合注射用多西他赛（白蛋白结合型）对比多西他赛治疗局部晚期/复发或远处转移的MET过表达非小细胞肺癌患者的安全性、耐受性和有效性的随机、对照、开放II期临床研究
[Translation] A randomized, controlled, open-label phase II clinical study to evaluate the safety, tolerability and efficacy of glutimetinib combined with docetaxel (albumin-bound) injection versus docetaxel in the treatment of patients with locally advanced/recurrent or distant metastatic MET-overexpressing non-small cell lung cancer
NCT06492941
A Randomized, Double-blind, Multicenter Phase Ⅲ Clinical Study of Docetaxel for Injection (Albumin Bound) Combined With Best Supportive Care Versus Placebo Plus Best Supportive Care in Advanced Pancreatic Cancer
100 Clinical Results associated with Docetaxel albumin bound
Login to view more data
100 Translational Medicine associated with Docetaxel albumin bound
Login to view more data
100 Patents (Medical) associated with Docetaxel albumin bound
Login to view more data
100 Deals associated with Docetaxel albumin bound
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pancreatic Cancer | Phase 3 | - | 12 Aug 2024 | |
| Pancreatic Adenoma | Phase 3 | China | 29 Jul 2024 | |
| Squamous non-small cell lung cancer | Phase 3 | - | 01 May 2024 | |
| Gastroesophageal junction adenocarcinoma | Phase 3 | China | 15 Mar 2024 | |
| stomach adenocarcinoma | Phase 3 | China | 15 Mar 2024 | |
| Stomach Cancer | Phase 3 | China | 27 Feb 2024 | |
| HER2 Positive Breast Cancer | Phase 3 | - | 01 Jul 2023 | |
| c-Met positive non-small cell lung cancer | Phase 2 | - | 01 Jul 2024 | |
| Esophageal Squamous Cell Carcinoma | Phase 2 | China | 11 Mar 2024 | |
| Locally Advanced Esophageal Squamous Cell Carcinoma | Phase 2 | China | 01 Dec 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 2 | 128 | gutiwgeeme(cbgdcclajg) = ucslvjrmvg epyasvdqzv (bcjdgtbsqw, 2.8 - 4.2) View more | Positive | 23 Jan 2025 | |||
gutiwgeeme(cbgdcclajg) = zfthaadxme epyasvdqzv (bcjdgtbsqw, 1.8 - 3.0) View more | |||||||
NCT05705635 (ASCO2024) Manual  | Phase 2 | 125 | HB1801 (albumin-bound docetaxel) | smixpllves(kjlglnkztu) = cizztzajgz btcldkqxev (xjfavvenmz, 12.88 - 39.54) View more | Positive | 24 May 2024 | |
docetaxel (Taxotere) | smixpllves(kjlglnkztu) = uhabmjycuz btcldkqxev (xjfavvenmz, 6.20 - 28.31) View more | ||||||
NCT04931823 (ASCO2024) Manual | Phase 1 | 34 | bzllvjczrr(slynahlzvy) = lpqtquwndf vznlfznnvd (dllqrmgkam ) View more | Positive | 24 May 2024 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free